2015 Bone Marrow Failure Disease Symposia

AA&MDSIF is co-sponsoring three symposia intended to provide updates on the most recent research related to the biology and clinical management of bone marrow failure bone marrow failure: A condition that occurs when the bone marrow stops making enough healthy blood cells. The most common of these rare diseases are aplastic anemia, myelodysplastic syndromes (MDS) and paroxysmal nocturnal hemoglobinuria (PNH). Bone marrow failure can be acquired (begin any time in life) or can be… diseases, including myelodysplastic syndromes myelodysplastic syndromes: (my-eh-lo-diss-PLASS-tik SIN-dromez) A group of disorders where the bone marrow does not work well, and the bone marrow cells fail to make enough healthy blood cells. Myelo refers to the bone marrow. Dysplastic means abnormal growth or development. People with MDS have low blood cell count for at… , aplastic anemia aplastic anemia: (ay-PLASS-tik uh-NEE_mee-uh) A rare and serious condition in which the bone marrow fails to make enough blood cells - red blood cells, white blood cells, and platelets. The term aplastic is a Greek word meaning not to form. Anemia is a condition that happens when red blood cell count is low. Most… , paroxysmal nocturnal hemoglobinuria hemoglobinuria: (hee-muh-gloe-buh-NYOOR-ee-uh) The presence of hemoglobin in the urine. , and myeloproliferative neoplasms. The overall goal of each continuing education symposium is to facilitate the translation of research findings into clinical practice and to improve the care of these patient populations.

At each event, local and national Hematology/Oncology experts will focus on the latest advances in the diagnosis, genetic characteristics, pathology, and treatment options for these diseases. The intended audience for the symposium includes hematologists, medical oncologists, internists, pathologists, residents/fellows, physician assistants, nurse practitioners, nurses, and allied health professionals treating patients with bone marrow failure diseases.